業績

2011年度研究業績
  1. 新 竜一郎, 佐藤 克也. 本年の動向 プリオン病の髄液診断の可能性. Annual Review神経. 2011;2011:121-9.
  2. 佐藤 克也, 調 漸. 【認知症学 下-その解明と治療の最新知見-】 臨床編 プリオン病の診断と治療 孤発性プリオン病 Kuru. 日本臨床. 2011;69(増刊10 認知症学(下)):423-6.
  3. Tsujino A, Kaibara M, Hayashi H, Eguchi H, Nakayama S, Sato K, et al. A CLCN1 mutation in dominant myotonia congenita impairs the increment of chloride conductance during repetitive depolarization. Neurosci Lett. 2011;494(2):155-60.
  4. Satoh K, Nakaoke R, Nishiura Y, Tsujino A, Motomura M, Yoshimura T, et al. Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms. J Neurol Neurosurg Psychiatry. 2011;82(8):942-3.
  5. Matsui Y, Satoh K, Miyazaki T, Shirabe S, Atarashi R, Mutsukura K, et al. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease. BMC Neurol. 2011;11:120.
  6. Koga T, Okada A, Kawashiri S, Kita J, Suzuki T, Nakashima Y, et al. Soluble urokinase plasminogen activator receptor as a useful biomarker to predict the response to adalimumab in patients with rheumatoid arthritis in a Japanese population. Clin Exp Rheumatol. 2011;29(5):811-5.
  7. Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Satoh K, Tamai M, et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology (Oxford). 2011;50(5):962-5.
  8. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175-8.
  9. Atarashi R, Sano K, Satoh K, Nishida N. Real-time quaking-induced conversion: a highly sensitive assay for prion detection. Prion. 2011;5(3):150-3.